Medicare Advantage vs. Medigap for Cancer Treatment
September 14, 2026
Medigap paired with Original Medicare gives you nationwide access to any oncologist or cancer center that accepts Medicare, with no referrals and no plan-level prior authorization for chemotherapy or radiation, but it comes with a higher monthly premium. Medicare Advantage plans usually cost less month to month and cap your yearly out-of-pocket spending, but they limit you to an in-network cancer center and commonly require prior authorization before treatment starts.
For someone facing a cancer diagnosis, or planning ahead in case of one, that difference in network access and cost predictability is often the deciding factor between the two paths. This guide walks through how each option handles provider access, prior authorization, and cost during active treatment so you can weigh the tradeoff for your own situation.
Quick Answer
Medigap paired with Original Medicare gives you nationwide access to any oncologist or cancer center that accepts Medicare, with no referrals and no plan-level prior authorization, but it costs more each month. Medicare Advantage plans usually cost less upfront and cap your yearly out-of-pocket spending, but they limit you to an in-network cancer center and often require prior authorization for chemotherapy and radiation. Neither plan pays for prescription drugs the same way: Medigap requires a separate Part D plan, while most Medicare Advantage plans bundle drug coverage in. The better fit depends on whether you value predictable network access or a lower starting premium.
Medicare Advantage vs. Medigap for Cancer Treatment
| Feature | Medicare Advantage | RecommendedMedigap + Original Medicare |
|---|---|---|
| Provider access | Limited to the plan's HMO or PPO network | Any provider nationwide that accepts Medicare |
| Access to a specific cancer center | Depends on whether the center is in-network that plan year | Access to any Medicare-participating cancer center |
| Prior authorization for chemo/radiation | Often required, varies by plan and drug | Not required by the Medigap policy itself |
| Annual out-of-pocket cap | Yes, an in-network limit set each year | No cap on Part A/B coinsurance, but Plan G/N cover most of it |
| Monthly premium | Often $0 to low-cost | Higher, especially for Plan G |
| Switching later without health questions | Can apply for Medigap anytime, but underwriting may apply | Guaranteed issue rights are strongest in specific windows |
How Provider Networks Affect Cancer Care
Medicare Advantage plans build networks of hospitals, oncologists, and infusion centers, and most use an HMO or PPO structure that limits or penalizes out-of-network care. That structure can create real disruption during cancer treatment if the network changes mid-year. In 2025, Mass General Brigham removed Dana-Farber Cancer Institute from at least one Medicare Advantage network, a shift covered in reporting on the Mass General Brigham and Dana-Farber network change. It shows how a network decision outside your control can affect access to a specific cancer center partway through treatment.
With Original Medicare and a Medigap policy such as Medicare Supplement Plan G or Medicare Supplement Plan N, you can see any oncologist, surgeon, or cancer center in the United States that accepts Medicare assignment, without a referral and without the network shrinking during your plan year. That matters if your cancer requires a specialist at an academic medical center or if you want a second opinion outside your local area.
If you're weighing specific Medicare Advantage plans, check each plan's Medicare star ratings for a general sense of plan quality, then confirm the oncology network directly with the cancer center's billing office rather than relying solely on the plan's online directory, since those directories are not always current.
Out-of-Pocket Costs During Active Treatment
Cancer treatment concentrates cost into a short window, which is exactly when the gap between Medicare Advantage and Medigap shows up most. Medicare Advantage plans must cap your yearly in-network out-of-pocket spending on Part A and Part B services, a federal requirement described on Medicare.gov. Once you hit that limit, the plan pays the full cost of covered in-network care for the rest of the year. Confirm the current-year limit on your plan's Annual Notice of Change or Summary of Benefits, since it's set annually.
Medigap works differently. Original Medicare pays 80% of the Medicare-approved amount for chemotherapy, radiation, and most outpatient cancer care, leaving you responsible for the other 20% with no annual cap unless a Medigap policy covers it. Plan G pays that 20% coinsurance in full after you meet the annual Part B deductible; Plan N pays it too, though Plan N adds small copays for some office and emergency room visits and does not cover Part B excess charges. Neither policy has a network, so your cost exposure stays the same anywhere in the country.
Prescription drugs, including oral chemotherapy and supportive medications, run through your Part D formulary under either path. Under the Inflation Reduction Act's redesign of the Part D benefit, out-of-pocket drug costs are capped at $2,000 for 2026, and that cap applies whether you get Part D through a stand-alone plan alongside Medigap or bundled into a Medicare Advantage plan. Compare the formulary for your specific cancer drugs before enrolling, since covered drug lists and cost tiers vary by plan even under the same annual cap.
Two Numbers That Shape Your Decision
Underwriting Risk After a Diagnosis
If you enroll in Medicare Advantage first and later want to switch to Medigap, insurers in most states can use medical underwriting to deny you a policy or charge more once you're outside your Medigap guaranteed issue window, and a cancer diagnosis can factor into that review. Guaranteed issue rights are strongest during your six-month Medigap open enrollment period, which starts the month you turn 65 and are enrolled in Part B. A few states, including Connecticut, Massachusetts, and New York, require insurers to sell Medigap policies year-round regardless of health status; rules vary elsewhere.
Which Coverage Fits Your Situation
Medicare Advantage tends to fit people who are healthy enough to accept network restrictions in exchange for a lower monthly premium and who are comfortable with prior authorization steps before starting treatment. It can also work well if your preferred cancer center is firmly in the plan's network and you don't expect to need out-of-state care.
Medigap tends to fit people who already have a cancer diagnosis, want unrestricted access to a specific specialist or academic cancer center, or who travel or split time between states and need coverage that works the same way everywhere. The tradeoff is a higher monthly premium in exchange for that predictability. Enrolling in Medigap during your initial guaranteed issue period, the six months right after you turn 65 and enroll in Part B, protects you from medical underwriting later, before any diagnosis is on record.
If you're already on Medicare Advantage and want to explore a change, read how switching from Medicare Advantage to Medigap works before you apply, since timing affects whether you'll need to answer health questions.
Questions to Ask Before You Choose
- Confirm your current oncologist and cancer center are in the plan's network, not just listed as accepting new patients
- Ask whether chemotherapy, radiation, and specialty cancer drugs require prior authorization under the plan
- Get the plan's current in-network annual out-of-pocket maximum in writing
- Check the Part D formulary for your specific cancer medications, including any oral chemotherapy drugs
- Ask what a second opinion at an out-of-network cancer center would cost under the plan
- If considering Medigap outside your initial enrollment window, ask about medical underwriting rules in your state
Get free Medicare guidance for cancer care decisions
Talk through your specific network, drug coverage, and cost questions with plain-language help. No pressure, no obligation.
Frequently Asked Questions
Yes, you can apply, but outside a guaranteed issue period most states allow the insurer to use medical underwriting, which can mean a higher premium or a denial based on your health history, including a cancer diagnosis. A few states, including Connecticut, Massachusetts, and New York, require insurers to sell Medigap policies year-round regardless of health status. Check your state's rules and read how switching from Medicare Advantage to Medigap works before you apply.
Many Medicare Advantage plans require prior authorization before you start chemotherapy, radiation, or certain imaging and specialty cancer drugs, and the specific list of services varies by plan and by year. Original Medicare, with or without a Medigap policy, does not add plan-level prior authorization on top of Medicare's own coverage rules.
Yes. Medigap policies pay according to Original Medicare's rules anywhere in the United States that accepts Medicare, so treatment at an out-of-state academic cancer center works the same way as treatment at home, as long as the provider accepts Medicare assignment.
It depends on how much care you need. Medicare Advantage usually has a lower monthly premium but shifts more cost to you through copays, coinsurance, and network limits, up to its annual out-of-pocket maximum. Medigap plans like Plan G have a higher monthly premium but cover most of the Part A and Part B cost-sharing gaps, so spending during active treatment is more predictable. Actual costs depend on your local premiums and provider network, so it's worth running the numbers on your specific options.
No. Medigap policies don't include prescription drug coverage, so you need a separate Part D plan to cover chemotherapy pills, anti-nausea medication, and other prescriptions. Compare each plan's Part D formulary for your specific cancer medications before enrolling, since coverage and tier placement vary by plan.